1-6 of 6
Timon Hansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-Year Evaluation of the German Clinical Amyloidosis Registry

Ute Hegenbart, Niklas Fuhr, Laura Huber, Christoph Kimmich, Kaya Veelken, Tobias Dittrich, Rita Ziehl, Fabian aus dem Siepen, Alexander Carpinteiro, Timon Hansen, Carsten Müller-Tidow, Axel Benner, Stefan Schönland
Journal: Blood
Blood (2021) 138 (Supplement 1): 3780.
https://doi.org/10.1182/blood-2021-152713
Published: 2021
Journal Articles

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Clinical Trials & Observations
Christoph R. Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Stefan Wörner, Jörg Beimler, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland
Journal: Blood
Blood (2020) 135 (18): 1517–1530.
https://doi.org/10.1182/blood.2019003633
Published: 2020
Includes: Supplemental data
Journal Articles

The Finding of Del 17p in Marrow Plasma Cells from Patients with Light-Chain Amyloidosis (AL) May Confer a Worse Prognosis

Sandy W. Wong, MD, Giovanni Palladini, MD PhD, Ute Hegenbart, MD, Heather Landau, MD, Melissa Warner, BS, Arnaud Jaccard, MD PhD, Herve Avet-Loiseau, Timon Hansen, MD, Joan Bladé, MD, María Teresa Cibeira, MD, Efstathios Kastritis, MD, Stefan Schönland, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2015) 126 (23): 3049.
https://doi.org/10.1182/blood.V126.23.3049.3049
Published: 2015
Journal Articles

Translocation t(4;14) Is Not an Adverse Prognostic Factor in Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation.

Timon Hansen, Georgia Schilling, Avichai Shimoni, Jose-Antonio Simon-Perez, Wolfgang Bethge, Peter Liebisch, Rainer Schwerdtfeger, Martin Bornhaeuser, Svenja Otterstetter, Francis Ayuk, Carsten Bokemeyer, Axel R. Zander, Jesus San-Miguel, Arnon Nagler, Nicolaus Kroeger
Journal: Blood
Blood (2007) 110 (11): 4743.
https://doi.org/10.1182/blood.V110.11.4743.4743
Published: 2007
Journal Articles

No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation.

Timon Hansen, Georgia Schilling, MD, Peter Liebisch, MD, Rainer Schwerdtfeger, PD, Jose Antonio Perez-Simon, MD, Martin Bornhaeuser, PD, Svenja Otterstetter, Judith Dierlamm, PD, Arnon Nagler, Dieter Kurt Hossfeld, Carsten Bokemeyer, Axel R. Zander, Nicolaus Kroeger, PD
Journal: Blood
Blood (2006) 108 (11): 5038.
https://doi.org/10.1182/blood.V108.11.5038.5038
Published: 2006
Journal Articles

Deletion of p53 as Detected by Fluorescence In Situ Hybridization Is Associated with Significant Shorter Event-Free Survival in Patients with Multiple Myeloma Who Are Receiving Allogeneic Blood Stem Cell Transplantation.

Georgia Schilling, MD, Timon Hansen, Jose Antonio Perez-Simon, MD, Rainer Schwerdtfeger, MD, Martin Bornhaeuser, MD, Svenja Otterstetter, Doris Seeger, Judith Dierlamm, PD, Francis Ayuk, MD, Hossfeld Dieter Kurt, Bokemeyer Carsten, Zander R. Axel, Kroeger Nicolaus, PD
Journal: Blood
Blood (2005) 106 (11): 4338.
https://doi.org/10.1182/blood.V106.11.4338.4338
Published: 2005